Evidence map›Paper›PMID 40791998›Full record

ArticleFrontiers in digital health2025

Parental perceptions of a wearable vital signs monitor for observation of newborns: in-depth interviews in three tertiary hospitals, Southwest Nigeria.

Yetunde Olufisayo John-Akinola, Adejumoke Idowu Ayede, Ayomide Adeyemi, Assumpta Nantume, Adesewa Oluwatomisin Olaleye, Olugbenga Akinrinoye, Olukemi Oluwatoyin Tongo, Michael Abe Alao, Adenike Oluleye, Oluseye Sobande and 10 more

Abstract read
In one paragraph

Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Yetunde Olufisayo John-AkinolaCollege of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria.
Adejumoke Idowu AyedeCollege of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria.
Ayomide AdeyemiCollege of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria.
Assumpta NantumeNeopenda, PBC, Chicago, IL, United States.
Adesewa Oluwatomisin OlaleyeCollege of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria.
Olugbenga AkinrinoyeCollege of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria.
Olukemi Oluwatoyin TongoCollege of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria.
Michael Abe AlaoCollege of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria.
Adenike OluleyeCollege of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria.
Oluseye SobandeCollege of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria.
Olatayo Sunday OlayemiCollege of Medicine, University of Ibadan and University College Hospital, Ibadan, Nigeria.
Bertha Akinyi OketchNeopenda, PBC, Chicago, IL, United States.
Rosena Olubanke OluwafemiMother and Child Hospital Akure, Akure, Ondo State, Nigeria.
Patricia Ireti EniowoMother and Child Hospital Akure, Akure, Ondo State, Nigeria.
Samuel OjoMother and Child Hospital Akure, Akure, Ondo State, Nigeria.
Omolayo Adebukola OlubosedeUniversity of Medical Sciences Teaching Hospital Complex, Akure, Ondo State, Nigeria.
Emmanuel Olaseinde BelloUniversity of Medical Sciences Teaching Hospital Complex, Akure, Ondo State, Nigeria.
Ismaila SaniUniversity of Medical Sciences Teaching Hospital Complex, Akure, Ondo State, Nigeria.
Teresa CauvelNeopenda, PBC, Chicago, IL, United States.
Sona ShahNeopenda, PBC, Chicago, IL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The first 28 days of a newborn's life are a critical time for their survival and subsequent growth and development. Wearable devices have emerged as a potential solution for clinical monitoring, offering affordability, accessibility, and improved patient care. This study explored the acceptability, satisfaction, and perceived benefits of the neoGuard wearable vital signs monitoring device among parents/guardians of sick newborns in Nigeria. Methods: This was a qualitative study conducted between April and December 2022 at three tertiary level health facilities in Nigeria. In-depth interviews were conducted with 17 parents/guardians whose newborns were monitored using the neoGuard technology. Participants were selected based on specific criteria, including observation of at least 2 h of use of the neoGuard technology on their newborn, and interviews were conducted in the participants' preferred language. Interviews were moderated with a semi-structured interview guide and audio recorded. Data were transcribed, coded and analyzed thematically using NVivo software. Results: The majority of participants expressed positive reactions to the neoGuard device, although some initial concerns were reported. Participants appreciated the device's functionality, ease of use, and potential to detect health issues in newborns. The device did not interfere with routine care activities such as cleaning, breastfeeding, or kangaroo care. Participants expressed high levels of confidence in the device's safety and expressed satisfaction with its performance. They suggested improvements such as designing the device to be worn on the wrist instead of the forehead. Conclusion: Overall, the neoGuard wearable vital signs monitor was well accepted by parents/guardians of sick newborns in Nigeria. The device's functionality, ease of use and potential to improve newborn health were positively perceived. Some suggestions for design improvements were provided. These findings highlight the importance of considering the perspectives of parents/guardians, alongside clinicians and other stakeholders, when implementing new technologies in clinical care. Further research should examine the device's clinical impact and cost-effectiveness while considering the experiences and perceptions of both healthcare providers and patients' guardians to inform adoption into clinical practice.

Indexed as

acceptabilitynewbornsparental perceptionssatisfactionwearable vital signs monitor

Identifiers

PMID40791998
PMCPMC12337009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.